Research ArticleCARDIOVASCULAR
Cardioprotective and Survival Benefits of Long-Term Combined Therapy with β2 Adrenoreceptor (AR) Agonist and β1 AR Blocker in Dilated Cardiomyopathy Postmyocardial Infarction
Ismayil Ahmet, Melissa Krawczyk, Weizhong Zhu, Anthony Yiu-Ho Woo, Christopher Morrell, Suresh Poosala, Riu-ping Xiao, Edward G. Lakatta and Mark I. Talan
Journal of Pharmacology and Experimental Therapeutics May 2008, 325 (2) 491-499; DOI: https://doi.org/10.1124/jpet.107.135335
Ismayil Ahmet
Melissa Krawczyk
Weizhong Zhu
Anthony Yiu-Ho Woo
Christopher Morrell
Suresh Poosala
Riu-ping Xiao
Edward G. Lakatta
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCARDIOVASCULAR
Cardioprotective and Survival Benefits of Long-Term Combined Therapy with β2 Adrenoreceptor (AR) Agonist and β1 AR Blocker in Dilated Cardiomyopathy Postmyocardial Infarction
Ismayil Ahmet, Melissa Krawczyk, Weizhong Zhu, Anthony Yiu-Ho Woo, Christopher Morrell, Suresh Poosala, Riu-ping Xiao, Edward G. Lakatta and Mark I. Talan
Journal of Pharmacology and Experimental Therapeutics May 1, 2008, 325 (2) 491-499; DOI: https://doi.org/10.1124/jpet.107.135335
Research ArticleCARDIOVASCULAR
Cardioprotective and Survival Benefits of Long-Term Combined Therapy with β2 Adrenoreceptor (AR) Agonist and β1 AR Blocker in Dilated Cardiomyopathy Postmyocardial Infarction
Ismayil Ahmet, Melissa Krawczyk, Weizhong Zhu, Anthony Yiu-Ho Woo, Christopher Morrell, Suresh Poosala, Riu-ping Xiao, Edward G. Lakatta and Mark I. Talan
Journal of Pharmacology and Experimental Therapeutics May 1, 2008, 325 (2) 491-499; DOI: https://doi.org/10.1124/jpet.107.135335
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement